Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.Neurobiology of Aging|May 9, 2017
The frequency and influence of dementia risk factors in prodromal Alzheimer's diseaseIsabelle Bos, Stephanie J Vos, Lutz Frölich, et al.Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.Biomedicines|November 27, 2021
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery CohortJin Xu, Rebecca Green, Min Kim, et al.Journal of Alzheimer'S Disease : JAD|January 28, 2020
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery CohortSarah Westwood, Alison L Baird, Sneha N Anand, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2019
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assayLiu Shi, Sarah Westwood, Alison L Baird, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2021
Harmonizing neuropsychological assessment for mild neurocognitive disorders in EuropeMarina Boccardi, Andreas U Monsch, Clarissa Ferrari, et al.Pageof 6